|

ELVN-001 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 2

Top Sponsors

  • Enliven Therapeutics2

Indications

  • Cancer2
  • Chronic Phase CML1
  • CML (Chronic Myelogenous Leukemia)1
  • Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive1
  • CML1

Other1 trial

ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
Phase 1

New York, New York1 trial

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

Memorial Sloan Kettering Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.